News

Union govt deploys Molbio Diagnostics’ to conduct door-to-door TB screening campaign

ET Health World, March 17, 2022

Molbio Diagnostics’ indigenously developed Truenat platform a point-of-care portable, battery-operated, IoT-enabled, Real Time PCR platform with a sample to result time of less than one hour to be used in the door-to-door campaign by health workers to test those found to have symptoms of TB

In Quest for Building Better Healthcare – Dr Chandrashekhar Nair

Arati Halbe, Research Matters, March 02, 2022

In an exclusive interview with Research Matters, Dr Chandrashekhar Nair, awardee of the Infosys Prize for Engineering and Computer Science 2021, shared the motivation, challenges and breakthroughs during the making of Truenat®, a portable, battery-operated PCR testing platform. 

RT-PCR test kit for Omicron ready, will approach ICMR if need arises, says TrueNat maker

The Print, December 18, 2021

Molbio Diagnostics director & chief technical officer Chandrasekhar Nair, awarded Infosys Prize 2021 this month, says they are waiting to see 'impact' of variant on public health.

Importance of Point-of-Care Testing in India

The Health Site, December 15, 2021

The ongoing COVID-19 pandemic has exposed the huge gaps in India's health care system and the need for novel point-of-care solutions

Infosys Prize 2021 highlights best of science, research in India

Team Lounge, Livemint, December 03, 2021

Chandrasekhar Nair, chief technology officer of Molbio Diagnostics in Bengaluru, was awarded the prize in engineering and computer science for the development and large-scale deployment of TrueNat, a new point-of-care testing platform for PCR-based medical diagnostics.

Three from Bengaluru bag Infosys Prize 2021

The Hindu, December 03, 2021

Chandrasekhar Nair, CTO of Molbio Diagnostics, for his development and large-scale deployment of TrueNat, a new point-of-care testing platform for PCR-based medical diagnostics.

Truenat is today fulfilling goal of being a multi-disease platform: Chandrasekhar Nair, Molbio Diagnostics

Shardul Nautiyal, Financial Express Health care, October 26, 2021

Truenat was validated extensively by ICMR and FIND for Indian and WHO approvals for sensitive and rapid detection of MDR-TB

Molbio Diagnostics receives DCGI nod for Scrub Typhus test

ET Health World; October 11, 2021, October 11, 2021

Truenat by Molbio is a point of care Real-Time PCR platform that had earlier been approved to detect numerous infectious diseases like COVID-19, Tuberculosis, H1N1, Dengue, Hepatitis amongst others

Speeding up medical intervention

The Navhind Time Desk, October 03, 2021

NT NETWORK speaks with founder-director and chief executive officer, Molbio Diagnostics, Sriram Natarajan to find out about Truenat, human diagnostics, trends in healthcare, and more

Diagnostics Sector In India: Challenges And Opportunities Presented By COVID-19 Pandemic

Longjam Dineshwori, The Health Site, September 21,2021, September 21, 2021

It underlined the need for simple point-of-care solutions that can be used by anyone, anywhere with minimal investments. Goa-based Molbio Diagnostics' Truenat platform, a point-of-care molecular diagnostics system, has been playing a significant role in the fight against COVID-19. The single platform can test 30+ diseases and share the results in less than an hour